ConBrella® Biodegradable PFO Occluder Approved by NMPA

ConBrella® Biodegradable Patent Foramen Ovale (PFO) Occluder System manufactured by Wuyou Tiaodong (WYTD) Medical Technology (Shenzhen) Co., Ltd. is officially approved by NMPA to launch in China. As the first PFO closure product in China to be approved through the “Green Channel,” ConBrella® marks a paradigm shift in structural heart disease treatment.

Redefining Heart Health with Bioresorbable Technology Traditional PFO treatments rely on permanent metal implants, which carry lifelong risks of erosion or arrhythmia. ConBrella® utilizes high-tech biodegradable materials (PDO and PLCL) that allow the device to safely degrade within the body after the PFO has healed.

Key Benefits:

• Complete Degradation: The device is replaced by the patient’s own tissue within approximately one year, leaving no foreign metal behind.
• Innovative Design: Features a world-first rivetless flexible integrated design for superior anatomical fit.
• Patient Peace of Mind: Eliminates the psychological and physical burden of living with a permanent metallic implant.

Following the successful national debut implantation at Fuwai Shenzhen Hospital in early April 2026, ConBrella® is now available to help patients aged 18–60 regain their health without leaving a trace.